Ustekinumab biosimilar(Eden Biologics)

乌司奴单抗生物类似药(Eden Biologics)

Report date: 2024/07/01 15:37:50

Base Information

Drug NameUstekinumab biosimilar(Eden Biologics)

Drug Alias NameJHL-1255EB-1004

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar

Mechanisms of ActionInterleukin-12 inhibitorsInterleukin-23 inhibitors

TargetsInterleukin-12Interleukin-23

Therapy Area/IndicationsPsoriasisCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEden Biologics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPsoriasisCrohn Disease

Inactive IndicationsN/A

ATC CodeN/A